文献速递介入腹部DSA

二维参数化实质血流灌注在肝细胞癌经动脉化疗栓塞中的应用:灌注变化定量及介入术后3个月肿瘤反应预测

Two-dimensional parametric parenchymal blood flow in transarterial chemoembolisation for hepatocellular carcinoma: perfusion change quantification and tumour response prediction at 3 months post-intervention.
PubMed 文献 · Clin Radiol · 2020-10-04

本研究纳入32例不可切除肝细胞癌患者,首次行载药微球经动脉化疗栓塞(DEB-TACE),利用二维参数化实质血流灌注(2D-PPBF)对数字减影血管造影序列进行后处理,定量分析栓塞前后灌注变化,并与3个月时mRECIST肿瘤反应进行相关性分析。结果显示栓塞前后各2D-PPBF参数均有显著差异,肿瘤反应与曲线下面积(AUC)变化相关(p=0.01,r=-0.45)。

要点

  • 2D-PPBF可客观定量DEB-TACE栓塞前后肿瘤组织灌注变化。
  • 栓塞后AUC、WIR及靶病灶大小显著下降,AP值显著升高。
  • AUC变化与3个月mRECIST肿瘤反应相关(p=0.01,r=-0.45)。

核心结论

  • 2D-PPBF为分析DEB-TACE栓塞后肿瘤组织灌注变化提供了客观方法,因此可用于预测肿瘤反应。

研究设计与样本

  • 研究纳入32例不可切除肝细胞癌患者(女性6例,男性26例,平均年龄67±8.9岁),均为首次接受DEB-TACE。
  • 对采集的数字减影血管造影(DSA)序列进行后处理,生成时间-密度曲线并计算2D-PPBF参数。
  • 以参考感兴趣区(ROI)为基准,计算wash-in率(WIR)、到达峰值时间(AP)和曲线下面积(AUC)的比值。
  • 采用Wilcoxon符号秩检验比较栓塞前后数据,并于3个月时采用mRECIST评估肿瘤反应,与2D-PPBF参数变化进行相关性分析。

诊断标准与关键数值

  • 基于ROI的时间-衰减曲线得出的所有2D-PPBF参数在DEB-TACE前后均有显著差异。
  • 栓塞后AUC、WIR及按mRECIST测量的靶病灶大小显著下降(p≤0.0001),AP值显著升高(p=0.0033)。
  • DEB-TACE后肿瘤反应与AUC变化相关(p=0.01,r=-0.45)。

临床应用与阅片要点

  • 作者认为2D-PPBF可用于预测DEB-TACE后的肿瘤反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the feasibility and potential value of two-dimensional (2D) parametric parenchymal blood flow (2D-PPBF) for the assessment of perfusion changes during transarterial chemoembolisation with drug-eluting beads (DEB-TACE) and to analyse correlations of 2D-PPBF parameters and tumour response.

MATERIALS AND METHODS: Thirty-two patients (six women, 26 men, mean age: 67±8.9 years) with unresectable hepatocellular carcinoma (HCC) who underwent their first DEB-TACE were included in this study. To quantify perfusion changes using 2D-PPBF, the acquired digital subtraction angiography (DSA) series were post-processed. Ratios were calculated between the reference region of interest (ROI) and the wash-in rate (WIR), the arrival to peak (AP) and the area under the curve (AUC) of the generated time-density curves. Comparisons between pre- and post-embolisation data were made using the Wilcoxon signed-rank test. Tumour response was assessed at 3 months using the modified Response Evaluation Criteria in Solid Tumours (mRECIST) and correlated to changes of 2D-PPBF parameters.

RESULTS: All 2D-PPBF parameters derived from the ROI-based time-attenuation curves were significantly different pre-versus post-DEB-TACE. Although the AUC, the WIR and target lesion size measured in accordance with mRECIST decreased (p≤0.0001) significantly, AP values showed a significant increase (p = 0.0033). Tumour response after DEB-TACE correlated with changes in the AUC (p = 0.01, r = -0.45).

CONCLUSION: 2D-PPBF offers an objective approach to analyse perfusion changes of embolised tumour tissue following DEB-TACE and can therefore be used to predict tumour response.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Becker LS, Maschke SK, Dewald CLA, et al. Two-dimensional parametric parenchymal blood flow in transarterial chemoembolisation for hepatocellular carcinoma: perfusion change quantification and tumour response prediction at 3 months post-intervention. Clin Radiol. 2020. PMID: 33028487. doi:10.1016/j.crad.2020.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。